Detalhe da pesquisa
1.
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.
Mol Ther
; 24(4): 832-42, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26743582
2.
Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa.
Front Immunol
; 14: 1186478, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529048
3.
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.
Vaccine
; 23(38): 4711-9, 2005 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16043269
4.
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.
J Gen Virol
; 83(Pt 1): 75-80, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11752703
5.
Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.
J Gen Virol
; 84(Pt 2): 361-368, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12560568
6.
Development of a DNA-MVA/HIVA vaccine for Kenya.
Vaccine
; 20(15): 1995-8, 2002 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-11983261
7.
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost.
J Gen Virol
; 84(Pt 1): 203-213, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12533717
8.
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
J Gen Virol
; 85(Pt 4): 911-919, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15039533